InflaRx N.V. IFRX Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$1.31 down $0.05, 3.69% at close Nov 6
Last close · Previous close $1.36
- Market cap
- $192.32MAt the Nov 6 close
- P/E ratio
- n/mLoss over last 12 months
- Diluted EPS
- −$0.39Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$1.31down $0.05, 3.69%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$1.36Nov 5
- Volume1.08MNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume1.11MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.80 to $2.95; now $1.31
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
IFRX beat the S&P 500 in 1 of 6 periods.
| Period | IFRX and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | IFRX: down 17.4% S&P 500: down 5.6% | IFRX trailed the S&P 500 by 11.8 percentage points Trailed |
| 3M | IFRX: down 24.1% S&P 500: down 4.1% | IFRX trailed the S&P 500 by 20.0 percentage points Trailed |
| YTD | IFRX: up 29.2% S&P 500: up 8.7% | IFRX beat the S&P 500 by 20.5 percentage points Beat |
| 1Y | IFRX: up 8.7% S&P 500: up 10.9% | IFRX trailed the S&P 500 by 2.2 percentage points Trailed |
| Long term | ||
| 3Y | IFRX: down 4.7% S&P 500: up 75.0% −1.6% vs +20.5% a year | IFRX trailed the S&P 500 by 79.7 percentage points Trailed |
| 5Y | IFRX: down 71.9% S&P 500: up 67.8% −22.4% vs +10.9% a year | IFRX trailed the S&P 500 by 139.7 percentage points Trailed |
$10,000 invested in IFRX 5 years ago (Nov 5, 2021) would be worth about $2,806 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $16,782.
IFRX beat the S&P 500 in 1 of 6 periods.
| Period | IFRX and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | IFRX: down 17.4% S&P 500: down 5.6% | IFRX trailed the S&P 500 by 11.8 percentage points Trailed |
| 3M | IFRX: down 24.1% S&P 500: down 4.3% | IFRX trailed the S&P 500 by 19.8 percentage points Trailed |
| YTD | IFRX: up 29.2% S&P 500: up 7.8% | IFRX beat the S&P 500 by 21.4 percentage points Beat |
| 1Y | IFRX: up 8.7% S&P 500: up 9.7% | IFRX trailed the S&P 500 by 1.0 percentage points Trailed |
| Long term | ||
| 3Y | IFRX: down 4.7% S&P 500: up 68.8% −1.6% vs +19.1% a year | IFRX trailed the S&P 500 by 73.5 percentage points Trailed |
| 5Y | IFRX: down 71.9% S&P 500: up 56.9% −22.4% vs +9.4% a year | IFRX trailed the S&P 500 by 128.8 percentage points Trailed |
$10,000 invested in IFRX 5 years ago (Nov 5, 2021) would be worth about $2,806 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $15,694.
All-time high
$51.61
Closing high on . Now 97.5% below that record.
Split-adjusted daily closes since Nov 7, 2017.
Stock splits
IFRX hasn’t split since its price history begins in 2017.
Valuation
The Nov 6 close compared with the last 12 months of reported results (the four quarters to Sep 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
n/mDiluted EPS of −$0.39 over the last 12 months
A P/E ratio isn’t meaningful while earnings over the last 12 months are negative. How to read P/E
Other valuation measures
- 1.2×Book value as of Sep 30, 2026
Price relative to accounting equity (book value) per share on the Sep 30, 2026 balance sheet. Asset-light companies often trade far above book value.
P/B = Price ÷ Book value per sharePrice-to-book ratio - −11.29%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $63.99MAt the Nov 6 close
What it would cost to buy the whole business: the market cap at the Nov 6 close, plus debt, minus cash and short-term investments from the Sep 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own IFRX DCF in Excel. Value InflaRx with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY26, the quarter ended Sep 30, 2026. “Last 12 months” means the four quarters from Oct 1, 2025 to Sep 30, 2026, and balance-sheet figures are as of Sep 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- −$39.87Kdown 153.9%
- Net income
- −$33.90M
- Diluted EPS
- −$0.39
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY24 (Dec 31, 2024) | −$440.17 | −$5.32M | −$0.08 |
| Q1 FY25 (Mar 31, 2025) | $0.00 | −$9.00M | −$0.14 |
| Q2 FY25 (Jun 30, 2025) | $46.39K | −$16.96M | −$0.25 |
| Q3 FY25 (Sep 30, 2025) | $27.97K | −$14.39M | −$0.21 |
| Q4 FY25 (Dec 31, 2025) | −$39.87K | −$12.51M | −$0.18 |
| Q1 FY26 (Mar 31, 2026) | $0.00 | −$6.47M | −$0.09 |
| Q2 FY26 (Jun 30, 2026) | $0.00 | −$12.16M | −$0.10 |
| Q3 FY26 (Sep 30, 2026) | $0.00 | −$2.76M | −$0.02 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $0.00 | −$51.68M | −$1.25 |
| FY22 (Dec 31, 2022) | $0.00 | −$31.43M | −$0.71 |
| FY23 (Dec 31, 2023) | $69.87K | −$47.25M | −$0.86 |
| FY24 (Dec 31, 2024) | $172.52K | −$47.93M | −$0.81 |
| FY25 (Dec 31, 2025) | $34.47K | −$53.62M | −$0.80 |
Margins
- Gross 14,418.5%
- Operating 94,754.3%
- Net 85,016.7%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- −$21.70MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow−$21.59MLast 12 months
- Capital spending$117.04KLast 12 months
- 54,434.0%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $143.98MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paidNot reportedLast 12 months
Balance sheet
- $174.93MAs of Sep 30, 2026
Cash plus short- and long-term marketable securities on the Sep 30, 2026 balance sheet.
- Total debt$917.60KAs of Sep 30, 2026
- Net cash$174.01MAs of Sep 30, 2026
- 7.26As of Sep 30, 2026
Current assets divided by current liabilities on the Sep 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.01As of Sep 30, 2026
Total debt divided by shareholders’ equity on the Sep 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- −32.2%Last 12 months
Over the last 12 months, InflaRx lost money: its net loss was 32.2% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - −27.4%Last 12 months
Over the last 12 months, InflaRx’s net loss was 27.4% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
About InflaRx N.V.
InflaRx N.V.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Germany
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
IFRX news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
IFRX stock FAQ
What is IFRX stock’s price today?
InflaRx (IFRX) traded at $1.31 at the close on , down $0.05 (3.69%) from the previous close of $1.36. Over the past 52 weeks it has traded between $0.80 and $2.95.
If you invested $1,000 in IFRX 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in IFRX on would be worth about $281 at the close on , a total return of −71.9%. The same $1,000 would be worth $1,088 if invested one year ago. Past performance doesn’t predict future returns.
What is InflaRx’s market cap?
InflaRx’s market capitalization is about $192.3 million. That’s Tiingo’s daily market cap for , at that day’s closing price of $1.31 (how market cap works). InflaRx reported 147.37M shares outstanding at the end of its latest quarter ().
What is IFRX’s P/E ratio?
IFRX’s P/E ratio isn’t meaningful right now because its earnings over the four quarters to are negative (diluted EPS of −$0.39).
What are IFRX’s earnings per share?
IFRX’s diluted earnings per share were −$0.39 over the four quarters to , compared with −$0.68 in the twelve months before. The latest quarter (Q3 FY26) brought −$0.02 per share, against −$0.21 a year earlier (how EPS works).
Does IFRX pay a dividend?
InflaRx hasn’t paid a dividend in the last twelve months.
What is IFRX’s 52-week high and low?
Over the past 52 weeks IFRX has traded as low as $0.80 and as high as $2.95. At $1.31 at the close on , it is 55.7% below that high and 63.5% above the low.
What is IFRX’s all-time high?
IFRX’s highest closing price was $51.61 on , adjusted for stock splits. At $1.31 at the close on , it is 97.5% below that record.
Has IFRX stock ever split?
No. IFRX hasn’t split since its price history begins in 2017.
How has IFRX stock performed?
Including dividends and measured to the close on , IFRX has returned +29.2% so far this year and +8.7% over the past year, and −71.9% over five years (−22.4% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is InflaRx in?
InflaRx is in the Healthcare sector and the Biotechnology industry, and is headquartered in Germany.
What exchange does IFRX trade on?
InflaRx trades on the Nasdaq under the ticker symbol IFRX. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.